These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 19331812
1. Ornithine decarboxylase regulates the activity and localization of rhoA via polyamination. Mäkitie LT, Kanerva K, Andersson LC. Exp Cell Res; 2009 Apr 01; 315(6):1008-14. PubMed ID: 19331812 [Abstract] [Full Text] [Related]
2. Ornithine decarboxylase induction in transformation by H-Ras and RhoA. Shantz LM, Pegg AE. Cancer Res; 1998 Jul 01; 58(13):2748-53. PubMed ID: 9661886 [Abstract] [Full Text] [Related]
3. Ornithine decarboxylase and extracellular polyamines regulate microvascular sprouting and actin cytoskeleton dynamics in endothelial cells. Kucharzewska P, Welch JE, Svensson KJ, Belting M. Exp Cell Res; 2010 Oct 01; 316(16):2683-91. PubMed ID: 20594968 [Abstract] [Full Text] [Related]
4. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Moshier JA, Dosescu J, Skunca M, Luk GD. Cancer Res; 1993 Jun 01; 53(11):2618-22. PubMed ID: 8495425 [Abstract] [Full Text] [Related]
5. High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyperacetylation. Hobbs CA, Gilmour SK. J Cell Biochem; 2000 Apr 01; 77(3):345-60. PubMed ID: 10760944 [Abstract] [Full Text] [Related]
6. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation. Iwata S, Sato Y, Asada M, Takagi M, Tsujimoto A, Inaba T, Yamada T, Sakamoto S, Yata J, Shimogori T, Igarashi K, Mizutani S. Oncogene; 1999 Jan 07; 18(1):165-72. PubMed ID: 9926931 [Abstract] [Full Text] [Related]
7. Relationship between ornithine decarboxylase and cytoskeletal organization in cultured human keratinocytes: cellular responses to phorbol esters, cytochalasins, and alpha-difluoromethylornithine. Pomidor MM, Ruhl KK, Zheng P, Song Y, Jänne OA, Tuan RS, Hickok NJ. Exp Cell Res; 1995 Dec 07; 221(2):426-37. PubMed ID: 7493642 [Abstract] [Full Text] [Related]
8. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells. Hayes CS, DeFeo K, Lan L, Paul B, Sell C, Gilmour SK. Oncogene; 2006 Mar 09; 25(10):1543-53. PubMed ID: 16278677 [Abstract] [Full Text] [Related]
9. Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity. Choi KS, Suh YH, Kim WH, Lee TH, Jung MH. Biochem Biophys Res Commun; 2005 Mar 04; 328(1):206-12. PubMed ID: 15670771 [Abstract] [Full Text] [Related]
10. Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E. Shantz LM, Hu RH, Pegg AE. Cancer Res; 1996 Jul 15; 56(14):3265-9. PubMed ID: 8764119 [Abstract] [Full Text] [Related]
11. Comparative effects of TGFbeta on proliferation of 7- and 14-day-old chick embryo fibroblasts and lack of involvement of the ODC/PA system in the TGFbeta signaling pathway. Evangelisti R, Valeno V, Bosi G, Baroni T, Bellucci C, Carinci P. J Cell Physiol; 1999 Mar 15; 178(3):304-10. PubMed ID: 9989776 [Abstract] [Full Text] [Related]
12. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression. Nilsson J, Grahn B, Heby O. Biochem J; 2000 Mar 15; 346 Pt 3(Pt 3):699-704. PubMed ID: 10698696 [Abstract] [Full Text] [Related]
13. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. Cañizares F, Salinas J, de las Heras M, Diaz J, Tovar I, Martinez P, Peñafiel R. Clin Cancer Res; 1999 Aug 15; 5(8):2035-41. PubMed ID: 10473083 [Abstract] [Full Text] [Related]
14. Stability of p21Waf1/Cip1 CDK inhibitor protein is responsive to RhoA-mediated regulation of the actin cytoskeleton. Coleman ML, Densham RM, Croft DR, Olson MF. Oncogene; 2006 May 04; 25(19):2708-16. PubMed ID: 16407839 [Abstract] [Full Text] [Related]
15. Antizyme inhibitor: a defective ornithine decarboxylase or a physiological regulator of polyamine biosynthesis and cellular proliferation. Keren-Paz A, Bercovich Z, Kahana C. Biochem Soc Trans; 2007 Apr 04; 35(Pt 2):311-3. PubMed ID: 17371267 [Abstract] [Full Text] [Related]
16. Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation. Shantz LM, Coleman CS, Pegg AE. Cancer Res; 1996 Nov 15; 56(22):5136-40. PubMed ID: 8912847 [Abstract] [Full Text] [Related]
17. Translocation of ornithine decarboxylase to the surface membrane during cell activation and transformation. Heiskala M, Zhang J, Hayashi S, Hölttä E, Andersson LC. EMBO J; 1999 Mar 01; 18(5):1214-22. PubMed ID: 10064588 [Abstract] [Full Text] [Related]
18. Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions. Keren-Paz A, Bercovich Z, Porat Z, Erez O, Brener O, Kahana C. Oncogene; 2006 Aug 24; 25(37):5163-72. PubMed ID: 16568078 [Abstract] [Full Text] [Related]
19. Effect of retinoic acid on transglutaminase and ornithine decarboxylase activities during liver regeneration. Ohtake Y, Maruko A, Ohishi N, Kawaguchi M, Satoh T, Ohkubo Y. Cell Biochem Funct; 2008 Apr 24; 26(3):359-65. PubMed ID: 18008394 [Abstract] [Full Text] [Related]
20. Polyamine depletion by ODC-AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo. Zhang B, Liu XX, Zhang Y, Jiang CY, Hu HY, Gong L, Liu M, Teng QS. J Gene Med; 2006 Aug 24; 8(8):980-9. PubMed ID: 16783835 [Abstract] [Full Text] [Related] Page: [Next] [New Search]